NASDAQ · ITOC

iTonic Holdings Ltd.

$0.25 -$0.02 (-6.19%) 1D Market open

Key Metrics

$4.52M
Market cap
P/E · TTM
$523.03K
Revenue · TTM
−$5.10M
Net income
EPS · TTM $-0.42
Dividend yield 0.2%
Free cash flow −$3.24M
Beta · 1Y 0.58
EBITDA · TTM
Gross margin 62.6%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    From its Jun 8 high, the share price fell 51%.

    Peak close $0.51 on Jun 8; trough close $0.25 on Jul 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -51%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 8
    The stock moved +80.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 8
  • Mar 25
    The stock moved +45.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 25

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$4.52M
Enterprise value
Shares outstanding17.1M
52-wk range$0.22 – $1.15
Avg volume · 20D2.0M
Net cash
Book value / share$0.51
ExchangeNASDAQ
About iTonic Holdings Ltd.
IPO dateSep 5, 2024
Employees7

iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S8.64
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 62.6%
Operating -974.8%
Net -974.7%
FCF -618.6%
ROE / ROIC -82.8% · -158.9%

Financial Health

Current ratio8.83
Quick ratio8.72
Debt / equity
Debt / EBITDA
Net cash
Working capital$3.63M

Cash Flow · TTM

Operating CF −$3.23M
Capex −$3.81K
Free cash flow −$3.24M
Buybacks
Dividends paid $8.91K
Shareholder yield 0.2%

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

0.6
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-06-30 · computed by TickerWolf from SEC filings